Earnings · US stocks
Ascendis Pharma A/S (ASND) earnings
Ascendis Pharma A/S published its quarterly report on 2026-11-12. The stock moved +4.80% in the 3 trading days after the report.
- Report
- quarterly report
- Published
- 2026-11-12
- Result
- Great
Stock move after the report
Trading days from the first tradeable session; dividend-adjusted. "vs index" is the excess return over CSI 300 for A-shares.
| After | Return | vs index |
|---|---|---|
| 1 day | +3.00% | — |
| 3 days | +4.80% | — |
Report history
Over the last 8 reports, EPS beat the consensus estimate in 5 of them. The stock rose in the 3 trading days after 6 of 8 reports (average +4.55%).
| Published | EPS | EPS surprise | 3 days after | 30 days after | 30d vs index |
|---|---|---|---|---|---|
| 2026-11-12 | 1.71 | +48.70% | +4.80% | — | — |
| 2026-08-13 | 0.90 | +17.39% | -3.16% | -9.69% | -9.00% |
| 2026-05-07 | 0.27 | +429.27% | +1.17% | -2.15% | -3.91% |
| 2026-02-11 | -0.55 | -124.49% | +0.87% | -0.40% | +6.37% |
| 2025-11-12 | -1.00 | -740.05% | +8.70% | +4.90% | +3.89% |
| 2025-08-07 | -0.64 | +49.30% | +2.96% | +3.85% | -1.12% |
| 2025-05-01 | -1.58 | -4.95% | -2.76% | +1.99% | -4.91% |
| 2025-02-12 | -0.64 | +45.35% | +23.82% | +25.21% | +31.22% |
The last 8 reported quarters. Moves count trading days from the first tradeable session after the report; "30d vs index" is the excess return over the market index.
How to read this
Results are grouped by reported profit growth (great, good, neutral, bad or a loss). For China A-shares the quality score starts at 100 and loses points for gaps a reader can check: operating cash falling short of profit, receivables or inventory outrunning revenue, profit that rests on one-off items or subsidies, heavy goodwill and a qualified audit opinion.
Figures are generated automatically from Wave Radar's published market data and refresh after each market close.